A Phase I Trial Of Vorinostat In The Treatment Of Advanced Laryngeal, Hypopharyngeal, Nassopahryngeal And Oropharyngeal Squamous Cell Carcinoma Of The Head And Neck

Trial Profile

A Phase I Trial Of Vorinostat In The Treatment Of Advanced Laryngeal, Hypopharyngeal, Nassopahryngeal And Oropharyngeal Squamous Cell Carcinoma Of The Head And Neck

Completed
Phase of Trial: Phase I

Latest Information Update: 12 Oct 2017

At a glance

  • Drugs Vorinostat (Primary) ; Cisplatin
  • Indications Head and neck cancer; Oropharyngeal cancer
  • Focus Adverse reactions
  • Most Recent Events

    • 07 Jun 2016 Status changed from recruiting to completed, as per an abstract presented at the 52nd Annual Meeting of the American Society of Clinical Oncology.
    • 07 Jun 2016 Results presented at the 52nd Annual Meeting of the American Society of Clinical Oncology
    • 29 Aug 2013 Planned End Date changed from 1 Jan 2013 to 1 Aug 2015 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top